Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
absorption.com

See what CB Insights has to offer

Partners & Customers

6

About Absorption Systems

Absorption Systems is developing GLP and GMP-compliant in vitro cell-based as well as in vivo animal models for clients in the pharmaceutical and gene/cell therapy space.On November 9th, 2020, Absorption Systems was acquired by Pharmaron at a valuation up to $137.5M.

Absorption Systems Headquarter Location

436 Creamery Way Suite 600

Exton, Pennsylvania, 19341,

United States

610-280-7300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Absorption Systems News

Building Out Carlsbad’s Industrial Base

Feb 28, 2022

Building Out Carlsbad’s Industrial Base Ted TchangPresident and CEOTechbilt Companies “There are a few places here and there, but there’s not very much left,” said Ted Tchang, president and CEO of Techbilt. “Like anything, real estate is cyclical. Right now, it’s as strong as I’ve ever seen it in my career,” Tchang said. “As the Carlsbad market has matured, we’ve seen the average business size increase. While the multi-tenant, small tenant space market is still very strong, we see the majority of the companies out there are looking in the larger size range that what we used to see, say 20 years ago.” High-End Campus First up on Techbilt’s construction list is Evolve, a three-building project totaling 67,714 square feet in the Oaks North Industrial Park, with construction expected to be finished in 16 to 18 months. “I guess you could say it’s a high-end flex building,” Tchang said. “We can accommodate everything from a light industrial manufacturing operation to a (company) headquarters.” Evolve is designed for life science, newer technology and research and development companies, according to Tchang. Conor BoyleSenior VPColliers International “It’s going to be a really high-quality, high-end campus with indoor/outdoor space where you can work inside or go outside and sit in the open air and work on your laptop,” said Conor Boyle, a senior vice president of the commercial real estate brokerage Colliers International. That will be followed by construction of a 145,000-square-foot industrial building, with delivery planned in 24 to 30 months, and then a two-building project totaling 140,000 square feet. Plans for that project could change, but construction is slated to finish in 24 to 30 months. Pinnacle Leased The new development comes after Techbilt in January leased a 63,900-square-foot building at 2820 Loker Ave. Absorption Systems, a pharmaceutical company based in Pennsylvania, signed a 10-year lease on the building for $11.5 million. Called Pinnacle, the building leased by Absorption Systems was built by Techbilt in 2018. Part of the delay in leasing the building was caused by the COVID 19 pandemic, but Tchang said Techbilt also was “looking for the right fit.” “Pretty much all the industrial buildings that I build, the plan is I’m going to hang onto them for a long time,” Tchang said. Pinnacle was delivered to Absorption Systems in shell condition. “They were able to get a brand new building that they could build out as they wanted,” Tchang said. In addition to interior tenant improvements, Absorption Systems is adding 16,000 square feet to the second floor of Pinnacle, bringing the final product to 79,900 square feet. Tight Demand

Absorption Systems Acquisitions

1 Acquisition

Absorption Systems acquired 1 company. Their latest acquisition was TGA Sciences on November 13, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/13/2017

$99M

Acquired

1

Date

11/13/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Absorption Systems Partners & Customers

6 Partners and customers

Absorption Systems has 6 strategic partners and customers. Absorption Systems recently partnered with U.S. Food and Drug Administration on September 9, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

9/19/2017

Partner

United States

Absorption Systems Embarks on Research Collaboration with the U.S. Food and Drug Administration.

EXTON , Pa. , Sept. 19 , 2017 / PRNewswire / -- Absorption Systems , a global leader in translational medicine and pharmacokinetic testing of drugs , announces a formal Research Collaboration Agreement with the U.S. Food and Drug Administration .

1

11/21/2016

Licensee

United Kingdom

Subscribe to see more

Subscribe to see more

10

10/7/2014

Client

Germany

Subscribe to see more

Subscribe to see more

10

7/15/2014

Licensor

United States

Subscribe to see more

Subscribe to see more

10

4/9/2013

Partner

India

Subscribe to see more

Subscribe to see more

10

Date

9/19/2017

11/21/2016

10/7/2014

7/15/2014

4/9/2013

Type

Partner

Licensee

Client

Licensor

Partner

Business Partner

Country

United States

United Kingdom

Germany

United States

India

News Snippet

Absorption Systems Embarks on Research Collaboration with the U.S. Food and Drug Administration.

EXTON , Pa. , Sept. 19 , 2017 / PRNewswire / -- Absorption Systems , a global leader in translational medicine and pharmacokinetic testing of drugs , announces a formal Research Collaboration Agreement with the U.S. Food and Drug Administration .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.